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0022-2836 © 2010 Elsevier Ltd. Open accIn the structure of bovine F1-ATPase inhibited with residues 1–60 of the
bovine inhibitor protein IF1, the α-helical inhibitor interacts with five of the
nine subunits of F1-ATPase. In order to understand the contributions of
individual amino acid residues to this complex binding mode, N-terminal
deletions and point mutations have been introduced, and the binding
properties of each mutant inhibitor protein have been examined. The N-
terminal region of IF1 destabilizes the interaction of the inhibitor with F1-
ATPase and may assist in removing the inhibitor from its binding site when
F1Fo-ATPase is making ATP. Binding energy is provided by hydrophobic
interactions between residues in the long α-helix of IF1 and the C-terminal
domains of the βDP-subunit and βTP-subunit and a salt bridge between
residue E30 in the inhibitor and residue R408 in the C-terminal domain of
the βDP-subunit. Several conserved charged amino acids in the long α-helix
of IF1 are also required for establishing inhibitory activity, but in the final
inhibited state, they are not in contact with F1-ATPase and occupy aqueous
cavities in F1-ATPase. They probably participate in the pathway from the
initial interaction of the inhibitor and the enzyme to the final inhibited
complex observed in the structure, in which two molecules of ATP are
hydrolysed and the rotor of the enzyme turns through two 120° steps. These
findings contribute to the fundamental understanding of how the inhibitor
functions and to the design of new inhibitors for the systematic analysis of
the catalytic cycle of the enzyme.© 2010 Elsevier Ltd. Open access under CC BY license.Introduction
Mitochondria contain a small basic inhibitor
protein known as IF1, which binds to the F1 catalytic
domain of the F1Fo-ATP synthase (F-ATPase)
complex. However, it has no effect on F-ATPases
from eubacteria or chloroplasts. This inhibitor
protein inhibits the ATP hydrolase activity of the
mitochondrial enzyme, but unlike almost all other
inhibitors of F1Fo-ATP synthase, which prevent both
hydrolysis and synthesis, it is a unidirectional
inhibitor and does not inhibit ATP synthesis.1–3
Bovine IF1 is 84 amino acids long,
4 and its structure
is a homo-dimer held together by an antiparallel
coiled coil of α-helices involving residues 49–81 iness:
orescent protein.
ess under CC BY license.the C-terminal region of each monomer.5 The N-
terminal regions, which are also largely α-helical,
contain the inhibitory sector. Each inhibitory sector
in the dimer binds to one of the three catalytic sites
in the F1 domains in two separate F1Fo complexes by
a mechanism in which each complex hydrolyses two
molecules of ATP.2,6 A monomeric fragment of IF1
consisting of residues 1–60 (I1-60) inhibits a single
F1Fo-ATPase complex. In a structure of bovine F1-
ATPase inhibited with I1-60, known as F1-I1-60,
6 the
inhibitor is bound at a catalytic interface between
the βDP- and αDP-subunits (see Fig. 1), and ADP–
magnesium complexes are trapped in the catalytic
sites of both the βDP- and βTP-subunits, whereas the
catalytic site in the βE-subunit is unoccupied except
for a phosphate molecule bound to the P-loop of the
subunit. In this complex, the inhibitor protein
appears to be bound to F1-ATPase predominantly
via residues 21–46 in the longer of its two α-helices.
These residues occupy a deep groove in the cleft
Fig. 1. The structure of bovine F1-ATPase inhibitedwith
residues 1–60 of the bovine inhibitor protein IF1. The α-, β-,
γ-, δ-, and ɛ-subunits are shown in ribbon representation in
red, yellow, dark blue, magenta, and green, respectively.
The inhibitor protein is light blue. (a) Side view of the
complex towards the catalytic interface between the αDP-
and βDP-subunits where the inhibitor protein is bound;
(b) cross-sectional view of the C-terminal domains of
the α- and β-subunits looking up along the axis of the
γ-subunit showing interactions of the inhibitor protein
with the subunits of F1-ATPase.
444 Mechanism of IF1 Inhibitionbetween the C-terminal regions of the βDP- and αDP-
subunits, whereas residues 47–50 extend beyond the
external surface of the F1-domain. This groove is
lined with segments of α-helices and loops in the C-
terminal domains of the βDP- and αDP-subunits and
with other similar features in the C-terminal
domains of the βTP- and αE-subunits. Residues
14–18 of IF1 make a second α-helix, which is linked
to the longer α-helix by an extended region contain-
ing residues 19 and 20. The shorter α-helix and the
region linking it to the longer α-helix make further
interactions with α-helical regions in the γ-subunit
in the central stalk, or rotor, of the enzyme. Residues
1–7 were not resolved in the structure, but residues
8–13 have an extended structure,which interacts with
the nucleotide binding domain of the αE-subunit.
Hence, I1-60 interacts with five of the nine subunits of
F1-ATPase.
Many of the amino acid residues of IF1, especially
in its longer α-helix, are conserved strictly, and
others have been substituted conservatively during
evolution (see Fig. 2).7 Therefore, as described here,
in order to understand their relative contributions to
the binding of IF1 to F1-ATPase, several N-terminally
truncated forms of I1-60 have been made, and point
mutations have been introduced into its longer
α-helix. The binding properties of the mutated
proteins have been studied quantitatively.Results and Discussion
Expression and characterization of inhibitor
proteins
The C terminus of residues 1–60 of bovine IF1 was
fused to the green fluorescent protein (GFP) in order
to enhance its expression in Escherichia coliwith a six-
histidine tag to facilitate protein purification. This
protein is known as I1-60GFPHis, and most of the
mutations were introduced into this version of IF1.
FiveN-terminally truncated versions of I1-60GFPHis
were made, and point mutations were introduced
into residues 21–45. Twelve inhibitor proteins with
some of the same point mutations were made in a
version of I1-60with a six-histidine tag fused directly
to its C terminus and lacking a GFP domain.
All of the inhibitor proteins were isolated by nickel
affinity chromatography. Their purities were dem-
onstrated by SDS-PAGE (Supplementary Fig. S1),
and their molecular masses were characterized by
electrospray ionization mass spectrometry (Supple-
mentary Table S1). The experimentally measured
mass values corresponded to the calculated values,
with one exception where the C-terminal His-tag
lacked one histidine residue. It is unlikely that this
change had any impact on the inhibitory properties
of the protein.
1       10         20         30         40         50         60
Bos taurus           GSESGDNVRS SAGAVRDAGG AFGKREQAEE ERYFRARAKE QLAALKKHKE NEISHHAKEI 
Homo sapiens          GSDQSENVDR GAGSIREAGG AFGKREQAEE ERYFRAQSRE QLAALKKHHE EEIVHHKKEI 
Rattus norvegicus       GSDSSESMDS GAGSIREAGG AFGKREKAEE DRYFREKTRE QLAALKKHHE DEIDHHSKEI 
Mus musculus         VSDSSDSMDT GAGSIREAGG AFGKREKAEE DRYFREKTKE QLAALRKHHE DEIDHHSKEI 
Saccharomyces cerevisiae  -SEGSTGTPR GSG----SED SFVKRERATE DFFVRQREKE QLRHLKEQ-- --LEKQRKKI 
Yarrowia lipolytica       -SEGSTGSYR GEG----SGD SFTKREKAQE DLYVKQQEKE KLDALRKQ-- --LNKLKQDT 
Pichia jadinii          -TAGATGATR QDG----STD AFEKREKAQE DLYIRQHEKE QLEALKES-- --LKKQKKSL 
 :  . .      *    : . :* ***:* * : :.: : :* :*  *::      : :  :. 
Fig. 2. Alignment of the sequence of residues 1–60 of bovine IF1 with equivalent portions of F1-ATPase inhibitor
proteins from other species. The purple, yellow, and green stripes denote strictly conserved, highly conserved, and poorly
conserved residues, respectively. The black lines above the sequences mark α-helical regions in bovine IF1. The Expasy
accession numbers for inhibitor proteins from Bos taurus, Homo sapiens, Rattus norvegicus, Mus musculus, Saccharomyces
cerevisiae, and Pichia jadinii are P01097, Q90112, Q03344, Q35143, P01097, and P09940, respectively.
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N-terminal deletions
Fig. 3. Influence of N-terminal deletions on the binding
of the inhibitor protein I1-60GFPHis to bovine F1-ATPase.
The data are taken from Supplementary Table S4. For an
explanation of the quotient Kimut:Kiwt, see the text.
445Mechanism of IF1 InhibitionAs described in Materials and Methods, the
inhibitory properties of the various inhibitor pro-
teins were assessed by measuring their binding
and dissociation rate constants, kon and koff, with
F1-ATPase.
8 A detailed description of the experimental
determination of kon and koff values for the inhibitors
containing the point mutations F22Y, E31A, and
F34A is provided in Materials and Methods, with
example data sets shown in Supplementary Figs. S2
and S3 and Supplementary Table S2. In one case, I1-
60His F22A, the addition of the inhibitor protein to
F1-ATPase gave rise to a linear, and not an
exponential, decrease in the activity of the enzyme;
consequently, the kon and koff values were not
determined. Therefore, the value of Ki was estimated
from a Lineweaver–Burke plot (Supplementary Fig.
S4). The values determined for kon, koff, and Ki of the
various inhibitors are summarized in Supplementa-
ry Tables S3 and S4. These values include those for
the wild-type I1-60GFPHis inhibitor protein, which
has a dissociation constant (Ki value) of 65 nM
−1,
and for the inhibitor protein I1-60 lacking both the
His tag and the GFP domain, where the Ki value of
30 nM−1 illustrates that the GFP moiety in I1-
60GFPHis weakens the ability of the inhibitor to
reach the site of inhibition. Nevertheless, I1-
60GFPHis is a potent inhibitor, and it provides an
appropriate comparator for the various mutant
derivatives.
Where the introduction of a point mutation
reduced the inhibitory potency of the protein
substantially, the mutated proteins were made
without the GFP domain, which is dominated by
β-structures, and the circular dichroism spectrum of
each protein was recorded. The circular dichroism
spectrum is recognised as a sensitive and accurate
means of assessing the α-helical content of a
predominantly α-helical protein.9 In Supplementary
Fig. S5, the spectra for the proteins with the point
mutations A21G, F22A, R25A, E30A, Y33A, F34A,
R35A, Q41A, L42A, A43V, A44V, and L45A are
compared with the spectrum of I1-60His (also
lacking a fused GFP domain). The spectra are very
similar, and there was no evidence that theintroduction of any of the mutations had disrupted
the long α-helix of I1-60His (Supplementary Fig. S6).
Therefore, the effects of the mutations on the
binding of the inhibitor protein can be attributed
directly to changes associated with the mutated
amino acid itself.
Role of the N-terminal region of IF1
In the structure of F1-I1-60, residues 1–7 were not
resolved, residues 8–13 have an extended structure,
and residues 14–18 form a short α-helix linked by
residues 19 and 20 to the longer α-helix, which starts
at residue 21.6 In the work presented here, five N-
terminally truncated inhibitor proteins were made
lacking residues 1–7, 1–13, 1–14, 1–15, and 1–16. All
of these truncated inhibitors had modestly higher
kon values in comparison with wild-type I1-60His,
whereas the value of koff did not increase substan-
tially until at least 14 residues had been deleted
(Supplementary Table S3). The effects of these
mutations are summarized in Fig. 3 as the quotient
of the dissociation constants of the wild-type and
mutant proteins, Kiwt:Kimut. Values of the quotient
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Fig. 4. Influence of point mutations in the long α-helix
of the inhibitor protein I1-60GFPHis on its binding to
bovine F1-ATPase. The mutations and their quantitative
effects on binding are given in Supplementary Table S4.
Kiwt and Kimut are the values for wild-type and mutant
proteins, respectively. Strictly conserved, highly con-
served, poorly conserved, and unconserved residues are
shown in purple, yellow, green, and white, respectively.
The unconserved residues G23, A36, and A38 were not
mutated.
446 Mechanism of IF1 Inhibitionthat are greater and less than unity correspond to
mutant proteins with increased and decreased
binding to F1-ATPase, respectively. The values
that were calculated (see also Supplementary
Table S3) demonstrate that residues 1–7 of I1-
60His do not contribute to the binding of IF1 to F1-
ATPase, and their deletion increased the binding
energy of I1-60His (Supplementary Table S3),
probably because the confinement of the N-terminal
region of the protein in the aqueous cavity in the
core F1-ATPase decreases its entropy. The inhibitor
protein I1-60GFPHis Δ1-7 is the most potent
inhibitor of all those that were made, with the
exception of I1-60GFPHis with the point mutation
Y33W (Supplementary Table S4). The role of
residues 1–7 of I1-60His may be to destabilize
the interaction between the inhibitor protein and
F1-ATPase, allowing it to leave its inhibitory site when
F1Fo-ATPase switches from the inhibited state to the
active ATP synthesising state. The roles of residues
8–12 were not investigated, but deletion of residues
beyond residue 12 weakened the interaction of the
inhibitor with F1-ATPase progressively up to
residue 15, where Kiwt:Kimut reached a local
minimum. The role of residues 13–20 seems to be
to help to impede the dissociation of the inhibitor
protein by interacting with the coiled-coil α-helical
region of the γ-subunit.
Effects of point mutations in the long α-helix
of I1-60
With the exceptions of the unconserved residues
G23, A36, and A38, the roles of the amino acids inthe long α-helix of I1-60 between residues 21 and 45
were investigated by changing non-alanine residues
to alanine and by changing alanine residues to
glycine (residue 21) or valine (residues 28, 43, and
44). Additionally, aromatic amino acids (F22, Y33,
and F34) were substituted conservatively. The
effects of many of these mutations are summarized
in Fig. 4 as Kiwt:Kimut values (see also Supplemen-
tary Table S4). They fall into three broad categories,
namely, those inhibitor proteins where the mutation
had a strong effect (Kiwt:Kimut=0–0.12), those
where the mutation had an intermediate effect
(Kiwt:Kimut=0.25–0.7), and those where the muta-
tion had either little or no effect or an apparent
stimulatory effect on the inhibitory properties of the
protein (Kiwt:KimutN1).Residues where mutation affects binding strongly
(Kiwt:Kimut=0–0.12)
Ten of the thirteen mutated residues in this
category are either strictly conserved (F22, R25,
A28, E30, F34, E40, and L45) or highly conserved
(A21, Y33, K39); one other residue, F34, is poorly
conserved; and A43 and A44 are unconserved.
Most of the residues in the category fall into two
distinct groups, 1 and 2. Group 1 consists of those
residues that contribute to the binding energy of IF1
in the final inhibited complex seen in the F1-I1-
60His structure, namely, residues F22, A28, E30,
Y33, F34, and L45 (Fig. 5). The roles of F22, Y33,
and F34 were studied by substituting them with
larger aromatic residues. The mutations F22Y,
F22W, and F34Y decreased the affinity of the
inhibitor for F1-ATPase, whereas Y33W increased
it (Supplementary Table S4). Group 2 contains
those residues (A21, R25, K39, E40, A43, and A44)
that, although they do not evidently contribute to
binding in the structure of the final inhibited
complex since they are in aqueous space, nonethe-
less influence strongly the ability of IF1 to form the
final inhibited state.Residues where mutation has an intermediate effect
(Kiwt:Kimut=0.25–0.7)
Of the four mutated residues where there was an
intermediate effect on Kiwt:Kimut (Q27, R37, Q41,
and L42), L42 is strictly conserved and Q27, R37,
and Q41 are highly conserved. L42 and Q41 belong
to group 1 and Q27 and R37 belong to group 2.Residues where mutation had either little or no
effect or a stimulatory effect (Kiwt:KimutN1)
Of the six residues in this category (K24, E26, E29,
E31, R32, and R35), two are strictly conserved (K24
and E26) and two others (E31 and R35) are highly
Fig. 5. Residues in the long α-helix of the bovine
inhibitor protein that contribute to its binding by inter-
acting directly with subunits of bovine F1-ATPase. The
inhibitor protein from residues 8–50 is pale blue, and α-
helical regions (residues 14–18 and 21–50) are shown in
ribbon representation. The extended N-terminal region
(residues 8–13) and the shorter α-helix snake around two
antiparallel α-helical regions (residues 1–23 and 232–251)
in the γ-subunit, which is part of the central stalk or rotor
of the enzyme. Residues with yellow side chains interact
with the βDP-subunit; the residue with a red side chain
interacts with the αDP-subunit; and the residue with a blue
side chain interacts with the βTP-subunit.
447Mechanism of IF1 Inhibitionconserved. These four residues form a third dis-
tinctly separate group of residues, group 3, which
are strictly or highly conserved, but their mutation
has no effect on forming either the final inhibited
state (group 1 residues) or intermediate state in the
pathway leading to the formation of the final
inhibited state (group 2 residues). The fifth and
sixth members of the category, E29 and R32, are
unconserved. They also seem to have no important
role in the inhibition process, but their lack of
conservation argues that whatever their role may be,
they are less important than the four members of
group 3.Fig. 6. Charged residues in the long α-helix of the
bovine inhibitor protein that are required for the binding
of the inhibitor to F1-ATPase but do not interact with F1-
ATPase in the structure of the inhibited complex. The long
α-helix of IF1 (residues 21–50; light blue) occupies an
aqueous cleft between the C-terminal domains of the βDP-
and αDP-subunits (yellow and red, respectively). The side
chains of amino acids that do not interact with the βDP-
and αDP-subunits, but nonetheless are required for the
formation of the inhibited complex, are dark blue.Roles of group 1 residues
The residues belonging to this group are F22, A28,
E30, Y33, F34, L42, L45, and Q41 (Fig. 5). With the
exception of F22 and A28, which sit in hydrophobic
pockets formed by residues I390 and L391 from
helix 1 in the βTP-subunit and residues A402 and
F403 from helix 2 in the αDP-subunit, respectively,
they make interactions, many of them hydrophobic,with helices 2 and 6 in the C-terminal domain of the
βDP-subunit (see Fig. 5).
6 Residues Y33, L42, and L45
are in contact with hydrophobic surfaces in helices 2
and 6, and F34 occupies a hydrophobic pocket made
from residues V404, S405, and R408 of the βDP-
subunit.6 As expected, mutation of the non-alanine
residues to alanine decreased the affinity of the
inhibitor for F1-ATPase, presumably by decreasing
the area of hydrophobic contact. In addition, the
introduction of bulkier aromatic side chains via the
mutations F22W, F22Y, and F34Y decreased the
affinity of the inhibitor, presumably because the
bulkier side chains of tyrosine and tryptophan
cannot be accommodated in the hydrophobic
binding pockets. In contrast, the substitution of
Y33 by tryptophan increased the binding of the
inhibitor, presumably by increasing the area of
hydrophobic contact with the βDP-subunit. The only
charged residue in the long α-helix to contribute in a
major way to the binding of the inhibitor protein to
F1-ATPase is residue E30, which forms a salt bridge
with R408 in helix 2 in the C-terminal domain of the
βDP-subunit.
6 In addition, the polar residue Q41
contributes to binding by interaction with D450 in
the loop linking helices 5 and 6 in the C-terminal
domain of the βDP-subunit. In the mutant inhibitor
containing the mutation A28V, the bulkier valine
residue will clash with helix 2 in the αDP-subunit in
Fig. 7 (legend on next page)
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449Mechanism of IF1 InhibitionF1-ATPase, thereby decreasing the affinity of the
inhibitor.
Roles of group 2 residues
The residues in this group are A21, R25, Q27, R37,
K39, E40, A43, and A44. In the crystal structure of
F1-I1-60His, the charged residues of this group do
not interact directly with F1-ATPase, and each of
them occupies an aqueous cavity (see Fig. 6).6
Nonetheless, the mutation of each of these residues
affected the binding of I1-60GFP to F1-ATPase,
indicating that they play roles at some as yet
undefined point in the pathway of the binding of
the inhibitor to the enzyme that leads to the
inhibited state observed in the crystal structure
(and possibly in its reversal). Neither A43 nor A44
interacts with F1-ATPase in the structure of bovine
F1-I1-60His. The substitutions A43V and A44V both
decreased the affinity of I1-60GFPHis for F1-ATPase
substantially, probably because the bulkier valine
residues clash with regions of F1-ATPase. It is
possible that A43 and A44 participate in making
an intermediate in the pathway leading to the final
inhibited state. This conclusion is rather tentative, as
is the inclusion of these two residues in group 2.
Group 3 residues
The residues in this group are K24, E26, E31, and
R35. In the structure of bovine F1-I1-60His, R35
appears to form a salt bridge with E399 in the αDP-
subunit.6 Therefore, it was surprising to find that the
mutation R35A had little effect on binding, and thus
it must be concluded that the salt bridge observed in
the structure is not a significant feature. In the
structure of a dimer of dimers of IF1, E26 forms a saltFig. 7. Possible schemes of the inhibition of F1-ATPase by th
away from the inner mitochondrial membrane from the foo
β-subunits that form the catalytic interface, where I1-60 binds,
are in red and yellow, respectively, and I1-60 is light blue.
represented schematically, and the corresponding α-subunits
binds first via the longer α-helix to the C-terminal domain of th
βE-subunits when the enzyme is in the ground state [PDB cod
enzyme involve many of the group 1 residues, E30, Y33, F34,
subsequent intermediates may also include the group 2 charged
of the γ-subunit through 120° closes the αEβE interface, conve
I1-60 into the αTP-βTP interface of the azide free ground state
binds to the αDPβDP interface in the final inhibited state (PDB co
not identical to the αDP βDP interface, and many of the intera
probably will be present at this stage. They include the interac
Q41, L42, and L45; orange). Also, it is possible that the group
point. However, residue F22 cannot interact with F1-ATPase
through 120° leads to the formation of the final inhibited struc
dead end state, where an ATP molecule has been hydrolysed a
in scheme (b), a pre-hydrolysis state, where an ATP molecule
interact with the βTP-subunit, completing the binding interacti
final inhibited state, the N-terminal region (purple) will also ibridge with H49 in a second dimer, apparently
helping to stabilize the inactive tetramer.4 It has
been suggested that this residue may be part of a
pH-sensitive switch that regulates the activity of IF1
by influencing its oligomeric state.5,10,11 The role of
K24 remains obscure. In addition, it is not clear why
the mutation E31A stimulated the inhibitory activity
of I1-60GFPHis.Comparison of the inhibition of bovine and yeast
F1-ATPases
The effects of the introduction of point mutations
into IF1 from Saccharomyces cerevisiae upon their
inhibitory activity with yeast F1-ATPase have been
studied independently by measuring the effect of
mutations on the inhibition of ATPase activity.12 It
was concluded that residues F17 (equivalent to
bovine F22), R20 (bovine R25), R22 (bovine Q27),
E25 (bovine E30), and F28 (bovine Y33) in the yeast
IF1 are essential for the activity of the inhibitor. In
addition, residues A23, R30, R32, Q36, L37, L40, and
L44 also play a role (the equivalent bovine residues
are A28, R35, R37, Q41, L42, L45, and H49,
respectively). With the exception of yeast R30
(bovine R35), these results are in broad agreement
with the results presented here for the inhibition of
bovine F1-ATPase by bovine IF1. R35 does not seem
to have a role in the inhibitory activity of bovine IF1.
Therefore, as presented elsewhere, the effects of the
mutation of R30 in yeast IF1 have been reassessed
with yeast F1-ATPase by measuring the kon and koff
of the wild-type yeast inhibitor and a form carrying
the mutation R30A (G. C. Robinson, J. V. Bason, M.
G. Montgomery, D. Mueller, A. G. W. Leslie, and J.
E. Walker, unpublished results). These measure-e inhibitor protein I1-60. F1-ATPase is depicted as viewed
t of the central stalk. For simplicity, only those α- and
are shown in ribbon representation. The α- and β-subunits
The remaining α- and β-subunits and the γ-subunit are
have been omitted for simplicity. Scheme (a) In state I, IF1
e βE-subunit in the catalytic interface between the αE- and
e 2JDI].13 These initial interactions between inhibitor and
Q41, L42, and L45 (orange), and the formation of this and
residues, R25, Q27, R37, K39, and Q41. In state II, rotation
rting it to the αTPβTP interface [PDB was made by docking
structure (PDB code 2JDI)13 at the same angle to which it
de 2v7q)6]. This αTP βTP interface is similar in structure but
ctions observed in the structure of the final inhibited state
tions formed by the group 1 residues of IF1 (E30, Y33, F34,
1 residue A28 (grey) may bind to the αTP-subunit at this
at this stage. In state III, further rotation of the γ-subunit
ture [PDB code 2v7q],6 either, as depicted in scheme (a), a
t the same catalytic interface that I1-60 binds, or, as shown
has not been hydrolysed.6 Residue F22 (purple) can now
ons between the long α-helix of IF1 and F1-ATPase. In this
nteract with the γ- and αE-subunits.
450 Mechanism of IF1 Inhibitionments show that the wild-type and mutant proteins
have almost identical Ki values. Residue L44 in yeast
IF1 was also proposed to play a role in the inhibition
of the yeast enzyme. The equivalent residue in the
bovine inhibitor, H49, was not studied in the work
described here. In the structure of bovine F1-I1-60 it
is found in the α-helical region of I1-60 that lies
beyond the external boundary of F1-ATPase, and in
a recently determined structure of yeast F1-ATPase
inhibited with yeast IF1, L44 is in a similar location
(G. C. Robinson, J. V. Bason, M. G. Montgomery, D.
Mueller, A. G. W. Leslie, and J. E. Walker,
unpublished results). The available structural infor-
mation does not suggest that this residue plays a
direct role in forming the inhibited complex.
The mechanism of binding of IF1 to F1-ATPase
In order for IF1 to gain access to and bind to its
complex binding site, it is reasonable to propose that
the initial interaction between the inhibitor and the
enzyme is formed with the C-terminal region of a
β-subunit in itsmost accessible and open conformation
during the catalytic cycle of ATP hydrolysis, namely,
the one represented by the βE-subunit, where no
nucleotide is bound (see Fig. 7). (An alternative view
that the initial interaction takes place with the βTP-
subunit has been advanced also.13) This initial
interaction with the βE-subunit may involve some
or all of the group 1 residues, E30, Y33, F34, Q41, L42,
and L45. It is also possible that group 2 residues such
as R25, Q27, R37, K39, and E40, which are not
making contacts with F1-ATPase in the final inhib-
ited complex, but where nonetheless mutation
influences the binding of the inhibitor, are also
involved in these early and intermediate binding
steps. Thus far, none of them has been characterized
structurally or kinetically, but it may be possible to
do so by forming a “ground state” analogue complex
of F1-ATPase with a non-hydrolysable form of ATP
or with ADP and beryllium chloride14,15 and by
estimating kon and koff with an inhibitor protein
bound appropriately to a surface plasmon resonance
chip. In order to proceed to the final observed
inhibited state, the γ-subunit must rotate through
240° in two consecutive 120° steps. In the first 120°
rotational step, which is driven by ATP binding at
the catalytic site in theβE-subunit, theβE-αE interface
is converted to the βTP-αTP interface. At this stage,
most of the important interactions between the
longer α-helix of IF1 and F1-ATPase, as observed in
the structure of F1-I1-60, are likely to have formed
already. Only during the second 120° rotational
step driven by ATP binding to the newly generated
βE-subunit can residue F22 of the inhibitor enter its
binding site in the hydrophobic pocket in the
adjacent β-subunit (the one that becomes the βTP-
subunit in the final inhibited state) and augment the
binding of the inhibitor to F1-ATPase (see Fig. 7). Theimportance of this residue in achieving the final
inhibited state is reflected by the impact on binding
of the introduction of the mutation F22A into the
inhibitor (Supplementary Table S4). During or after
this second 120° rotational step, it is likely that the
interactions between the γ-subunit and the shorter
α-helix (residues 14–18 of IF1) and the region linking it
to the longer α-helix (residues 19–21) will also form.
The mechanism of the reversal of the inhibition of
F1Fo-ATPase by IF1, in response to the imposition of
a proton-motive force to drive ATP synthesis, is not
known. However, the restoration of ATP synthesis
requires the reversal of the direction of rotation of
the rotor of the enzyme from the counterclockwise
direction that accompanies ATP hydrolysis, as
viewed from the membrane domain of the enzyme,
to the clockwise direction required for ATP synthe-
sis. This reversal of the direction of rotation of the
rotor evidently destabilizes the interactions of IF1
with the F1-domain of the inhibited enzyme leading
to its eventual ejection from the inhibited catalytic
interface. It seems likely that the interactions
between residues 14–20 of IF1 with the rotor itself
will be destabilized in the early part of this reversal
of inhibition, and that residues 1–7 will contribute to
the destabilization of the binding of IF1. As the
inhibited catalytic interface opens in response to the
reversed rotation of the rotor, the interaction of
residue F22 with the βTP-subunit will be broken,
followed at a later stage by the disruption of
interactions between the long α-helix of IF1 and
the C-terminal domain of the β-subunit that
formerly had been the βDP-subunit in the final
inhibited state, and the release of IF1.
Practical implications
Knowledge about which residues of IF1 are most
important for forming the inhibited complex has
practical significance. First, because of the complex-
ity of the mode of binding of IF1 to F1-ATPase and its
high affinity for F1-ATPase, bovine IF1 is highly
specific and selective for the ATPase activity of
bovine F1Fo-ATP synthase. These properties have
been put to use in a simple affinity chromatography
method for purifying the inhibited bovine complex
(M. J. Runswick, J. V. Bason, I. M. Fearnley, and J. E.
Walker, unpublished results). Since F1Fo-ATPases
are highly conserved in vertebrates, this method has
been used to purify of the human, sheep, pig, rabbit,
and mouse enzymes, and a similar procedure has
been developed for purifying the enzyme from
fungal species (T. Charlesworth, M. J. Runswick, J.
V. Bason, I. M Fearnley, S. Ferguson, and J. E.
Walker, unpublished results). In developing these
procedures, knowledge of how to strengthen or
weaken the interaction of I1-60 with the F1-domain
by introducing appropriate mutations has proved to
be very valuable. Second, a comparison of the
451Mechanism of IF1 Inhibitionstructures of bovine and yeast F1-ATPases inhibited
by their cognate inhibitor proteins has shown that
although the inhibited complexes are very similar in
many respects, there are differences as well. The
most notable is that although the inhibitors bind in a
similar way to F1-ATPases, their modes of binding
are not identical; the yeast inhibitor binds at a
slightly steeper angle relative to the central rotor of
the enzyme than the bovine inhibitor. As a
consequence of these subtle differences in binding
mode, the catalytic cycle of the yeast enzyme has
been arrested at an earlier stage than in the bovine
inhibited complex, revealing a new intermediate
state in the catalytic pathway of the enzyme (G. C.
Robinson, J. V. Bason, M. G. Montgomery, D.
Mueller, A. G. W. Leslie, and J. E. Walker,
unpublished results). In this intermediate state, an
ATP molecule has been hydrolysed, and both
phosphate and magnesium have been released
from the αEβE catalytic interface, whereas the
nucleotide, ADP, remains bound. This finding offers
the prospect that it may be possible, using the
information given in the present study, to engineer
new forms of I1-60 that arrest the catalytic cycle of
bovine F1-ATPase at other as yet uncharacterized
intermediate stages and to characterize the inter-
mediates by structural analysis.†http://www.embl.de/∼andrade/k2d.htmlMaterials and Methods
Overexpressionandpurificationof recombinant proteins
An expression plasmid encoding residues 1–60 of
bovine IF1 with the enhanced green fluorescent protein
fused to its C terminus, followed by a hexahistidine
sequence, was cloned into plasmid pRun. The encoded
protein is referred to as I1-60GFPHis. Single, double, and
triple point amino acid mutations were introduced into
this sequence with a series of pairs of synthetic comple-
mentary oligonucleotide primers containing the mutated
codons and 24 bases 5′ and 3′ of the codon, respectively.
This region was amplified by PCR and extended in a
second PCRwith primers flanking the 5′ and 3′ ends of the
coding sequence for I1-60GFPHis. The template plasmid
contained restriction digest sites for NdeI and HindIII 5′
and 3′ of the gene, respectively, and thus the modified
sequences were restricted and religated into the predi-
gested plasmid, pRun, to produce the requisite expression
plasmids. The procedure was repeated to produce
expression plasmids for mutant inhibitor proteins not
containing GFP.
Cells of E. coli C41 (DE3)16 were transformed with
plasmids encoding wild-type and mutant forms of I1-
60GFPHis and I1-60His. Cells were grown in 2xTY
medium at 37 °C. When the cell density had reached an
absorbance of 0.6 at 600 nm, protein expression was
induced with isopropyl-β-D-thiogalactopyranoside
(0.286 mg/ml final concentration). After 18-h growth at
25 °C, cells were harvested by centrifugation (6500g,
10 min). They were resuspended in buffer A [20 mM Tris–HCl (pH 7.4), 10% (v/v) glycerol, 25 mM imidazole, and
0.1 M sodium chloride] and broken with a Constant Cell
disruptor (Constant Cell, Daventry, UK). All subsequent
steps were performed at 4 °C. Cell debris was removed by
centrifugation at 265,000g for 1 h. The supernatant was
filtered through a Minisart membrane (pore size, 0.2 μm;
Sartorius, Goettingen, Germany) and applied to a Hi-Trap
nickel Sepharose column (GE Healthcare, Buckingham-
shire, UK) equilibrated in buffer A. I1-60GFPHis, I1-60His,
and mutant forms were eluted with a linear gradient of
imidazole from 25 to 300mM in a total volume of 100ml of
buffer A. Fractions containing the proteins were pooled
and dialysed for 4 h against 2 l of buffer consisting of
20 mM Tris–HCl (pH 7.4) and concentrated to 24 mg/ml
with a VivaSpin concentrator (molecular weight cutoff,
5 kDa; Sartorius, Göttingen, Germany).
Protein analysis
The purification of proteins was monitored by SDS-
PAGE in 12–22% acrylamide gradient gels. Proteins were
detected by staining with Coomassie brilliant blue dye.
The sequences of recombinant inhibitor proteins were
verified by measurement of their molecular masses by
electrospray mass spectrometry in either a triple quadru-
pole-time of flight mass spectrometer (Q-Tof1, Micromass-
Waters, Altrincham, UK) or a Quatro Ultima triple
quadrupole instrument (Micromass-Waters). Samples of
the various inhibitor proteins (1–2 μM in 1–2% formic acid
in 50% aqueous acetonitrile) were introduced into an
electrospray interface by flow injection. Spectra were
recorded from 700 to 2000 m/z (mass-to-charge ratio)
and processed with Mass Lynx software (Micromass-
Waters). Any discrepancies were investigated by sequenc-
ing the expression plasmid.
Estimation of the α-helical contents of proteins
Mutant inhibitor proteins lacking the fused GFP domain
were dialysed for 18 h against ultra-pure water. They were
diluted to a concentration of 0.125 mg/ml and their
circular dichroism spectra were recorded from 190 to
260 nm with the aid of a Jasco J-810 spectropolarimeter
(Jasco Inc., Easton, MD, USA). The secondary structure of
the protein was calculated with the program K2D†.
Assay of inhibition of F1-ATPase
Bovine F1-ATPase was purified from heart mitochon-
dria as described previously.17 Its ATP hydrolase activity
in the presence of the various inhibitors was measured
with an ATP-generating system by the addition of 2.5 μg
of F1-ATPase (specific activity; 101 μmol/mg/min) to 1 ml
of assay mixture at 37 °C. The assay mixture consisted of
50 mM potassium chloride, 50 mM Tris–HCl (pH 8.0),
2 mM magnesium chloride, 0.2 mM NADH, 1 mM
phosphoenol-pyruvate, 2 mM ATP, pyruvate kinase
(80 μg/ml), and lactic acid dehydrogenase (80 μg/ml).18
Each mutant inhibitor protein, dissolved in 20 mM Tris–
452 Mechanism of IF1 InhibitionHCl (pH 7.4; concentration, 20 mg/ml) was added 20 s
after the addition of enzyme to give a final concentration
of inhibitor between 0.05 and 0.3 μM. The absorbance at
340 nm was recorded for 10 min with each inhibitor at six
different concentrations.
The rate constants of binding to and dissociation from
F1-ATPase, kon and koff, respectively, of each inhibitor
protein were measured from the exponential decay of the
rate of ATPase activity after the addition of various
amounts of inhibitor protein. The change in absorbance of
NADH with time is given by:
y tð Þ − y0 = Vltl + V0 − Vlð Þ = kinhð Þ 1 − exp −kinhtð Þð Þð Þ
where y is the absorbance at 340 nm, t is time, kinh=kon[I]
+koff, V0 is the initial rate of reaction, and V∞ is the rate of
reaction at equilibrium.
In the presence of a large excess of inhibitor protein over
F1-ATPase, the reaction rate constants become pseudo-first
order, and thus the relationship becomes concentration
dependent. Thus, kinh varies with respect to [I], and the
association and dissociation constants are determined
from the straight line plot of kinh=kon[I]+koff, where kinh
and koff, the rate constants for inhibitor dissociation, are
expressed in inverse seconds; inhibitor concentration [I] is
expressed as a molarity (μM); and kon, the rate constant for
inhibitor binding, is expressed as μM−1 s−1.8 The dissoci-
ation constant for the inhibitor binding to enzyme, Ki, was
calculated from Ki=koff/kon, where Ki is the dissociation
constant for inhibitor binding to enzyme, koff is the rate
constant for inhibitor dissociation, and kon is the rate
constant for inhibitor binding. The change in free energy of
binding,ΔΔGbinding, brought about by the mutations, was
calculated from ΔΔGbinding=−RTln(Kiwildtype/Kimutant),
where Ki
wildtype and Ki
mutant are the dissociation constants
for the binding to the enzyme for the wild-type and
mutated inhibitor proteins, respectively, and R is the gas
constant and T the temperature in Kelvin. Sample
analyses are given for the mutant inhibitor proteins
F22Y I1-60GFP, E31A I1-60GFPHis, and F34A I1-
60GFPHis in Supplementary Data. The decrease in
ATPase activity as a result of an increase in inhibitor
concentration is given (Supplementary Fig. S3) together
with calculated apparent rate constants, kinh, for each
inhibitor concentration (Supplementary Table S5) and
plots of [I] versus kinh (Supplementary Fig. S4).Structural data
Structural data concerning the bovine F1-I1-60 complex
[PDB code 2v7q] are displayed in Figs. 1, 4, 5, and 7 with
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